APLM

Apollomics Inc.

Healthcare · Pharmaceutical Preparations

$23.85Sep 28, 2026

AI confidence 70% · refreshes every 15s during session

Investment Snapshot

Moderate evidence · 2 sources

Why it matters

Apollomics Inc. shows accelerating business momentum based on AlphaOS pipeline evidence, with mixed management execution.

Why it matters: Revenue +0% YoY in Q1 FY2026.

TrajectoryAccelerating
ExecutionMixed

2 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

  • Revenue +0% YoY in Q1 FY2026
  • Revenue Growth

Pipeline evidence · 22d ago

APLM's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on APLM.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q1 2026

Full APLM earnings analysis

Reported figures for Apollomics Inc. — research only, not investment advice.

Revenue YoY
0.0%

Latest Intelligence

Updated

What happened recently for Apollomics Inc. (APLM) — events, not interpretation.

Event
Reported Q1 2026 revenue 0% YoY.
Also
Last session September 28, 2026 at $23.85.
Source
Q1 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Apollomics Inc. (APLM)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Apollomics Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$52.36M
Revenue:
$8.50M

APLM earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Apollomics Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.